Combination Therapy Patterns and Predictors of ADHD in Commercially Insured and Medicaid Populations

In commercially insured and Medicaid ADHD populations, combination therapy rates differed by medication class, as did the demographic and clinical characteristics statistically significantly associated with combination therapy. This suggests that these medications may be used differently in clinical practice.